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Introduction {#sec1}
============

The intestinal epithelium is maintained by intestinal stem cells (ISCs), which reside at the bottom of the crypt ([@bib15]). ISCs are identified by the expression of specific genes, such as leucine-rich repeat-containing G-protein-coupled receptor 5 (*Lgr5*) ([@bib1]). The differentiation of intestinal epithelial cells (IECs) predominantly proceeds in a unidirectional manner, starting from the ISCs to the terminally differentiated cells. In the earliest phase of this process, progenitor cells are committed either to a secretory or absorptive lineage based on the expression of key transcription factors such as atonal homolog-1 (ATOH1) or hairy and enhancer of split-1 (HES1) ([@bib9], [@bib33]).

However, a recent study showed that small-intestinal IECs committed to the absorptive lineage can exhibit ISC-oriented de-differentiation upon severe epithelial damage ([@bib28]). Other studies have further highlighted the plasticity and ISC-oriented de-differentiation of secretory lineage-committed IECs in the small intestine, which are identified by the expression of NGN3 ([@bib22]), Delta-like 1 (DLL1) ([@bib30]), and doublecortin-like kinase 1 (DCLK1) ([@bib32]). ATOH1^+^ label-retaining cells (LRCs) reside at the +4 position and serve as secretory progenitor cells, but they can also exhibit ISC properties upon severe tissue injury ([@bib3]). These studies indicated that a collective proportion of ATOH1^+^ secretory lineage-committed IECs retain their potential to revert to ISCs and can exhibit ISC-specific properties upon severe tissue injury to compensate for the massive loss of genuine ISCs ([@bib14]). Consistent with this finding, a recent single-cell analysis of LGR5^+^ IECs identified the rare presence of ATOH1^+^LGR5^+^ double-positive cells in normal small-intestinal crypts ([@bib11]). However, the comprehensive and dynamic contributions of these ATOH1^+^ potential ISCs under normal and pathologic conditions have yet to be described. In addition, the key factors that can recruit a specific subset of ATOH1^+^ IECs back to the ISC pool upon severe epithelial damage remain mostly uncertain.

In intestinal tumorigenesis, several studies have shown that LGR5^+^ ISCs are the cells of origin of sporadic adenomatous polyposis coli (*Apc*)-deficient tumors (bottom-up model) ([@bib2]). Other studies have shown that villus cells can initiate tumor development through overexpression of GREM1 or constitutive activation of the nuclear factor kappa-B (NF-κB) pathway ([@bib5], [@bib23]). These studies raise the possibility that de-differentiation of lineage-committed IECs may constitute another pathway of intestinal tumorigenesis (top-down model). Accordingly, inflammatory bowel disease (IBD) patients develop colitis-associated cancers (CACs) via a pathway distinct from that of sporadic colon cancers. Established CACs are abundant in Atoh1^+^ cells and, thus, retain features of secretory lineage-committed cells, such as mucin production ([@bib19]). The robust expression of ATOH1 in CACs may be supported by environmental tumor necrosis factor alpha (TNF-α) and contributes to maintaining their highly malignant properties ([@bib7]). However, the potential contribution of ATOH1^+^ secretory lineage-committed IECs as the origin of CAC tumor stem cells has yet to be described.

In this study, using the ATOH1^+^ cell-lineage-tracing model, we showed that colonic ATOH1^+^ IECs could give rise to functional ISCs under both homeostatic and pathologic conditions. The results highlight the unexpectedly broad contribution of ATOH1^+^ IEC-derived ISCs to the maintenance, regeneration, and progression of colitis-associated tumorigenesis in the colonic epithelium.

Results {#sec2}
=======

Lineage Tracing of ATOH1^+^ IECs Labels Secretory Lineage IECs {#sec2.1}
--------------------------------------------------------------

To elucidate the dynamic contribution of ATOH1^+^ IECs to the maintenance of the intestinal epithelium, we planned a lineage-tracing experiment. Here, we crossed *Atoh1*^*Cre-PGR*^ mice ([@bib20]) with *Rosa26-LSL-tdTomato* reporter mice to generate *Atoh1*^*Cre-PGR*^*; Rosa26-LSL-tdTomato* mice (*Atoh1*^*tdTomato*^ mice, [Figure 1](#fig1){ref-type="fig"}A). In these mice, the effect of haploinsufficiency due to the knockin allele could not be observed, as confirmed through the analysis of *Atoh1* mRNA and protein expression in the small intestine and colon ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C). To optimize the RU486-mediated tdTomato labeling of ATOH1^+^ IECs, we compared the labeling efficiency between a single dose of RU486 and the injection of RU486 for 5 consecutive days. Both protocols successfully labeled ATOH1^+^ IECs in the crypts of the small intestine and colon ([Figure 1](#fig1){ref-type="fig"}B). The 5-dose protocol resulted in a higher labeling efficiency ([Figure 1](#fig1){ref-type="fig"}C) and was therefore employed in the majority of the following experiments.Figure 1Establishment of ATOH1^+^ Cell-Lineage Tracing(A) Schematic representation of the alleles used to establish the *Atoh1*^*tdTomato*^ mice.(B) Co-staining of ATOH1 (green) and tdTomato (red) in small-intestinal and colonic tissues. *Atoh1*^*tdTomato*^ mice were administered RU486 in either a single dose (single dose) or for 5 consecutive days (five-dose) and were then analyzed on the day following the final treatment. Note that all of the tdTomato^+^ IECs co-expressed ATOH1.(C) Quantification of ATOH1^+^ IEC labeling efficiency based on the analysis shown in (B). Data are expressed as the mean ± SEM of biological replicates (n = 3). ^∗^p \< 0.05, N.S., not significant.(D) Co-staining of secretory IEC markers (green) and tdTomato (red). tdTomato-labeled MUC2^+^ goblet cells, CHGA^+^ enteroendocrine cells, DCLK1^+^ tuft cells, and Lysozyme^+^ Paneth cells are shown (yellow arrowheads).(E) Co-staining for Ki-67 (green) and tdTomato (red) revealed tdTomato^+^ Ki-67^+^ double-positive IECs (yellow arrowheads).(F) Immunostaining of CD24 using small-intestinal and colonic tissue of a wild-type mice.(G) Representative flow plots of the small-intestinal IECs recovered from the *Atoh1*^*tdTomato*^ mice on the day after completion of the five-dose RU486 treatment and EdU labeling. The CD24^high/mid^ tdTomato^+^ fraction (combined population of CD24^high^ and CD24^mid^ cells) was further analyzed based on EdU labeling (right).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

The analysis performed 24 hr after a single dose of RU486 showed that all secretory lineage IECs and some Ki-67^+^ IECs were initially labeled by tdTomato ([Figures 1](#fig1){ref-type="fig"}D and 1E). Conversely, all of the tdTomato^+^ IECs were completely negative for HES1 ([Figure S1](#mmc1){ref-type="supplementary-material"}D) and for other absorptive lineage markers ([Figure S1](#mmc1){ref-type="supplementary-material"}E). To further confirm the labeling of mitotic IECs, the uptake of 5-ethynyl-2′-deoxyuridine (EdU) was examined in ATOH1^+^ IECs. Using CD24 as a marker for lower crypt IECs ([Figure 1](#fig1){ref-type="fig"}F) ([@bib21]), we found that 4.7% of the CD24^high/mid^ tdTomato^+^ IECs were also positive for EdU ([Figure 1](#fig1){ref-type="fig"}G).

These results collectively confirmed that our ATOH1^+^ IEC lineage-tracing system initially labeled both post-mitotic and mitotic secretory lineage-committed IECs in a highly specific manner.

Atoh1^+^IECs that Retain an ISC-like Phenotype Exist within Normal Intestinal Crypts {#sec2.2}
------------------------------------------------------------------------------------

LGR5^+^ ISCs are located at the bottom of the crypt between Paneth cells ([@bib1]). To determine whether any LGR5^+^ ISCs were labeled by our lineage-tracing system, we crossed our *Atoh1*^*tdTomato*^ mice with *Lgr5-EGFP-IRES-creERT2* mice to generate *Lgr5-EGFP-IRES-creERT2; Atoh1*^*Cre-PGR*^; *Rosa26-LSL-tdTomato* mice (*Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice). The induction of *Atoh1*^*Cre-PGR*^ allele-dependent tdTomato labeling in *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice showed that the tdTomato^+^ IECs were clearly distinct from LGR5^+^ ISCs ([Figure 2](#fig2){ref-type="fig"}A). However, flow cytometric analysis of ATOH1^+^ IECs revealed a rare population of LGR5-EGFP^+^ ATOH1^+^ double-positive IECs in the small intestine of *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice ([Figure 2](#fig2){ref-type="fig"}B). Consistently, RNAscope *in situ* hybridization (RNAscope ISH) clearly exhibited *Lgr5*^+^*Atoh1*^+^ double-positive cells, most frequently at the +4 position or +3 position of the small intestine and colon, respectively ([Figure 2](#fig2){ref-type="fig"}C). The integrity of our RNAscope analysis was validated by using positive control tissues ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). Also, tdTomato^+^ crypt cells co-expressing *Ascl2* were found in both regions ([Figure 2](#fig2){ref-type="fig"}D).Figure 2ATOH1^+^ IECs Include a Cell Population that Retains the Expression of Stem Cell-Specific Genes(A) Co-staining of Lgr5-EGFP (green) and tdTomato (red) in the small-intestinal and colonic crypts of *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice on the day following the completion of the five-dose RU486 treatment.(B) Representative flow plots of the small-intestinal IECs recovered from the *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice on the day following the completion of the five-dose RU486 treatment.(C) RNAscope *in situ* hybridization (RNAscope ISH) for Lgr5 (green) and Atoh1 (red) in the small-intestinal and colonic crypts of wild-type mice. The white dotted line shows the cell margin of a *Lgr5*^+^*Atoh1*^+^ double-positive cell. Position number of *Lgr*5^+^*Atoh1*^*+*^ double-positive cells (n = 30 of three independent experiments for each analysis) within a crypt was determined based on its relative position from the bottom of the crypt. Images of the colon are re-used in [Figure 4](#fig4){ref-type="fig"}C.(D) Co-analysis of RNAscope ISH for *Ascl2* (green), with immunostaining for tdTomato (red). *Ascl2*^+^tdTomato^+^ double-positive cells are identified in the small-intestinal and colonic crypt. A magnified view of the area identified by the white square is shown in the right side.(E) qRT-PCR analysis of CD24^high^, CD24^mid^, and CD24^low^ IECs in the small intestine of the wild-type mice (n = 3). Small-intestinal LGR5^high^ IEC population of the *Lgr5*^*EGFP*^ mice (n = 3) served as a positive control for ISCs. Data are expressed as the mean ± SEM. ^∗^p \< 0.01.(F) Representative flow plots of the small-intestinal IECs recovered from the *Atoh1*^*tdTomato*^ mice on the day following the completion of the five-dose RU486 treatment.(G and H) qRT-PCR analysis of cell fractions that were acquired in (F).Data are expressed as the mean ± SEM of values normalized by the expression of β-actin (n = 3 of biological replicates). ^∗^p \< 0.01, ^∗∗^p \< 0.05.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

CD24 is commonly expressed by small-intestinal and colonic crypt IECs ([Figure 1](#fig1){ref-type="fig"}F) and therefore used to identify and isolate LGR5^+^ ISCs or Paneth cells ([@bib31]). Our analysis of the CD24^high^, CD24^mid^, and CD24^low^ fraction of small-intestinal IECs confirmed that the CD24^high^ and CD24^mid^ population includes LGR5^+^ ISCs, Paneth cells, and enteroendocrine cells ([Figure 2](#fig2){ref-type="fig"}E). In contrast, the CD24^low^ population did not include these cell populations. Therefore, the combined population of CD24^high^ and CD24^mid^ small-intestinal IECs (CD24^high/mid^) was collected from the *Atoh1*^*tdTomato*^ mice on the day after the administration of a single dose of RU486 and sorted into tdTomato^+^ and tdTomato^−^ cell fractions ([Figure 2](#fig2){ref-type="fig"}F). qRT-PCR analysis of these cell populations showed that gene markers for secretory cell progenitors (*Dll1*) and genes recently identified as markers of LRCs (*Nfatc3*, *Nfat5*) ([@bib3]) were highly expressed in the CD24^high/mid^ tdTomato^+^ IECs ([Figure 2](#fig2){ref-type="fig"}G). Exceptionally, CD82 showed highest expression in CD24^high/mid^tdTomato^−^ IECs, indicating its preferential expression in the Atoh1^−^ IEC population. In addition, ISC markers such as *Lgr5, Olfm4*, and *Ascl2* presented the highest expression in the CD24^high/mid^tdTomato^−^ population ([Figure 2](#fig2){ref-type="fig"}H). However, expression of these genes was also detected in the CD24^high/mid^tdTomato^+^ IEC population, although at a much lower level. These results sufficiently indicated that ATOH1^+^ IECs in the normal intestinal epithelium consist of a heterogeneous cell population, including secretory lineage progenitor cells, and a small population of IECs retaining ISC-specific gene expression.

Atoh1^+^ IECs Constitutively Exhibit ISC Properties under Homeostatic Conditions {#sec2.3}
--------------------------------------------------------------------------------

To identify the possible contribution of ATOH1^+^ IECs as potential ISCs, the dynamic changes in the tdTomato^+^ IEC distribution were traced for up to 20 days. On day 6, tdTomato^+^ IECs were found both in the crypts and in the villi, showing mostly a scattered distribution pattern ([Figure 3](#fig3){ref-type="fig"}A). At a later phase, the overall number of tdTomato^+^ IECs showed a clear decrease, indicating that most of these cells exhibit only a short lifetime. However, we found clusters of tdTomato^+^ IECs in both the small intestine and the colon on day 13 and day 20 ([Figure 3](#fig3){ref-type="fig"}A). These tdTomato^+^ IEC clusters clearly formed a continuous array of IECs along the crypt-villus axis, indicating that they represent clones of IECs arising from a common ATOH1^+^ IEC-derived ISC origin. Thus, we would like to designate these clusters of IECs as ATOH1^+^ IEC-derived clonal ribbons (ATOH1^+^ICRs), representing crypts dominated by ATOH1^+^ IEC-derived ISCs. The incidence of ATOH1^+^ICR generation was higher in the colon than in the small intestine, reaching up to 1.0 ribbon per 1,000 crypts ([Figure 3](#fig3){ref-type="fig"}B). No ATOH1^+^ICR formation was found by RU486 treatment in mice carrying *Rosa26-LSL-tdTomato* allele alone (*Null*^*tdtomato*^) or by vehicle-alone treatment in *Atoh1*^*tdTomato*^ mice. Compared with the previous lineage tracing of small-intestinal DLL1^+^ IECs ([@bib30]) or DCLK1^+^ IECs ([@bib32]), colonic ATOH1^+^ IECs formed clonal ribbons at a frequency that was at least 10-fold higher under homeostatic conditions. Such a regional difference may simply represent the preferential labeling efficiency of our system or may represent the difference in the population size of ATOH1^+^ IECs that retain ISC-like properties. Also, as we did not use a multi-color reporter, it remains possible that the ATOH1^+^ICRs observed *in vivo* may not necessarily represent a single-clone origin but may be composed of multi-cell origin.Figure 3ATOH1^+^ IECs Give Rise to LGR5^+^ ISCs that Can Form Clonal Ribbons under Homeostatic Conditions(A) Lineage tracing in *Atoh1*^*tdTomato*^ mice showing the formation of tdTomato^+^ clonal ribbons (ATOH1^+^ICRs) in the small intestine and colon. Mice were treated by the five-dose protocol of RU486 and killed for analysis on day 6, day 13, and day 20.(B) Quantification of ATOH1^+^ICR formation frequency in the small intestine and colon, using the tissue sections of *Atoh1*^*tdTomato*^ mice or mice carrying *Rosa26-LSL-tdTomato* allele alone (*Null*^*tdtomato*^). *Atoh1*^*tdTomato*^ mice treated with vehicle alone (vehicle, n = 3), or *Null*^*tdtomato*^ mice treated with RU486 (n = 3) served as negative control. Atoh1^+^ICR was defined as those clusters of tdTomato^+^ cells completely occupying the whole crypt-villus unit, as assessed by the examination of at least three serial sections. The number of ATOH1^+^ICR was normalized against the total number of crypts. Data are expressed as the mean ± SEM.(C) Co-staining of cell-lineage markers, such as MUC2, CHGA, DCLK1, Villin, CA2, and Lysozyme (green) with tdTomato (red) on day 20.(D) Co-staining of Ki-67 (green) and tdTomato (red) in the Atoh1^+^ICR observed on day 20.(E) Fluorescence images of tdTomato^+^ cells (red) co-expressing Lgr5-EGFP (green) in the ATOH1^+^ICR of *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice on day 20. Mice were treated as described in (A).(F) Successful establishment of tdTomato^+^ organoids from the small-intestinal and colonic tissues recovered from *Atoh1*^*tdTomato*^ mice on day 20.(G) The efficiency of tdTomato^+^ organoid formation was quantified using tissues collected from the *Atoh1*^*tdTomato*^ mice. Total cumulative number of tdTomato^+^ organoids acquired from four mice is normalized by the total number of organoids.(H) Representative flow plots showing the increased presence of Lgr5-EGFP^+^tdTomato^+^ IECs in the small intestine of the *Lgr5*^*EGFP-CreERT2*^*Atoh1*^*tdTomato*^ mice on day 20 compared with the data on day 6 shown in [Figure 2](#fig2){ref-type="fig"}B.(I) Designated cell fractions in (H) were subjected to microarray analysis and then compared and analyzed for the adult stem cell-specific gene set (M1999) by GSEA.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

These ATOH1^+^ICRs contained all lineages of differentiated IECs and Ki-67^+^ IECs ([Figures 3](#fig3){ref-type="fig"}C and 3D), thereby indicating the possibility that the resident ATOH1^+^ IECs had acquired genuine ISC-specific function and thus took over the whole crypt-villus unit.

Accordingly, analysis of the ATOH1^+^ICRs in *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice showed the clear existence of LGR5-EGFP^+^tdTomato^+^ double-positive IECs in ATOH1^+^ICRs ([Figure 3](#fig3){ref-type="fig"}E). To further verify the acquisition of ISC properties by ATOH1^+^ IECs, we employed the organoid culture system. Small-intestinal or colonic tissues from *Atoh1*^*tdTomato*^ mice were subjected to organoid culture at 20 days after RU486 induction. Among the established organoids, we found organoids that completely consisted of tdTomato^+^ IECs ([Figure 3](#fig3){ref-type="fig"}F). These tdTomato^+^ organoids could be re-organized across passages. The efficiency of forming these tdTomato^+^ organoids was highly consistent with the time-dependent appearance of ATOH1^+^ICRs *in vivo* ([Figure 3](#fig3){ref-type="fig"}G). Induction of ATOH1^+^ICR formation appeared to be driven by an IEC-intrinsic mechanism, as tdTomato^+^ organoids could be formed through RU486-mediated induction *in vitro* ([Figure S3](#mmc1){ref-type="supplementary-material"}A) and maintained beyond passaging ([Figure S3](#mmc1){ref-type="supplementary-material"}B). However, the efficiency of forming tdTomato^+^ organoids *in vitro* was lower in the organoids of *Atoh1*^*tdTomato*^ mice than in those of *Lgr5-EGFP-IRES-creERT2; Rosa26-LSL-tdTomato* mice (*Lgr5*^*tdTomato*^ mice) ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D). In addition, tdTomato^+^ organoids could be re-organized from a single tdTomato^+^ cell, also at a lower frequency compared with LGR5^high^ cells ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F). Those single-cell-derived tdTomato^+^ organoids could be re-organized beyond passaging ([Figure S3](#mmc1){ref-type="supplementary-material"}G) and give rise to both secretory and absorptive cells ([Figure S3](#mmc1){ref-type="supplementary-material"}H). These results indicate the acquirement of multi-potency by ATOH1^+^ IECs *in vitro*.

To further identify the properties of ATOH1^+^ IEC-derived ISCs, LGR5-EGFP^+^tdTomato^+^ double-positive ISCs were collected from *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice on day 20 ([Figure 3](#fig3){ref-type="fig"}H), and global gene expression in these cells was compared with LGR5-EGFP^+^ single-positive ISCs. Gene set enrichment analysis (GSEA) showed that the expression of stem cell-signature genes in LGR5-EGFP^+^tdTomato^+^ double-positive ISCs was comparable with that in LGR5-EGFP^+^ single-positive ISCs ([Figure 3](#fig3){ref-type="fig"}I). These results confirmed that a specific population of ATOH1^+^ IECs is constitutively re-directed to exhibit genuine ISC-specific properties and participate in the maintenance of the normal intestinal epithelium.

Colonic Inflammation Promotes the Generation of ATOH1^+^ IEC-Derived Clonal Ribbons {#sec2.4}
-----------------------------------------------------------------------------------

Following epithelial injury, various signaling pathways are activated within the intestinal epithelium to aid in optimization of the regeneration program ([@bib16]). In the present study, only a minimal increase in the number of small-intestinal ATOH1^+^ICRs was observed following irradiation-induced damage (control group, 0.20 ribbons per 1,000 crypts; irradiation group, 0.63 ribbons per 1,000 crypts; data not shown). Thus, we examined whether the recruitment of colonic ATOH1^+^ IECs to the ISC pool and the subsequent formation of ATOH1^+^ICRs could be enhanced in a dextran sodium sulfate (DSS) colitis model. A significant reduction in body weight in the DSS-colitis mice indicated the successful induction of colitis ([Figure S4](#mmc1){ref-type="supplementary-material"}A). At day 2, we found only a small number of tdTomato^+^ IECs in the rectum of DSS-colitis mice ([Figure S4](#mmc1){ref-type="supplementary-material"}B). However, at day 6, we found clear increase in the number of tdTomato^+^ IECs in DSS-colitis mice ([Figure 4](#fig4){ref-type="fig"}B). At this time period, LGR5^+^ATOH1^+^ double-positive cells were not clearly identified in the rectal crypts of DSS-colitis mice ([Figure 4](#fig4){ref-type="fig"}C). However, a clear and persistent existence of ATOH1^+^ IECs was observed in the rectum of these DSS-colitis mice ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D). Accordingly, a significant increase in the mucosal area occupied by tdTomato^+^ IECs was observed during the recovery phase (day 6, day 13, and day 20) of the damaged mucosa ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F). Importantly, ATOH1^+^ICRs appeared in the rectum of DSS-colitis mice as early as day 6, a time period when they were never observed in the control mice. Some of the massive tdTomato^+^ area in the DSS-colitis mice at day 13 represented a cluster of tdTomato^+^ IECs extending from the ulcer-edge crypts, which covered the surface of the adjacent wound ([Figure 4](#fig4){ref-type="fig"}D). This observation indicated that ATOH1^+^ IEC progenies actively contribute to the early phase of tissue repair by forming the wound-associated epithelium ([@bib24]). Consequently, we found an increase in the number of ATOH1^+^ICR formation and massive clusters of ATOH1^+^ICRs in the rectum of DSS-colitis mice at a later phase (day 20, [Figures 4](#fig4){ref-type="fig"}E and 4F). Such an increase in the number of ATOH1^+^ICR was never found by pre-labeling ATOH1^+^ cells before DSS treatment ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H), thus indicating that colitis-induced ATOH1^+^ICR formation is initiated by ATOH1^+^IEC-derived cells that are less sensitive to DSS-induced damage, or ATOH1^+^ cells that have newly appeared during the post-DSS labeling period.Figure 4Formation of ATOH1^*+*^ IEC-Derived Clonal Ribbon Is Significantly Promoted during Regeneration from Colitis-Induced Epithelial DamageFormation of ATOH1^*+*^ IEC-derived clonal ribbon (ATOH1^+^ICR) was compared between the DSS-colitis mice (DSS) and control mice (Control).(A) Experimental design for the lineage-tracing analysis of Atoh1^+^ IECs in DSS-colitis-induced *Atoh1*^*tdTomato*^ mice.(B) Labeling of ATOH1^+^ IECs-derived cells by tdTomato (red) at day 6 in the colon of DSS-colitis mice and control mice.(C) Double RNAscope ISH showing expression of *Atoh1* (red) and *Lgr5* (green) in the colonic crypts of DSS-colitis mice and control mice. Magnified view of the designated area (white square) is shown in the right end column. Images of the colon are re-used in [Figure 2](#fig2){ref-type="fig"}C.(D) An example of ATOH1^+^ICR forming the wound-associated epithelium in DSS-colitis mouse on day 13.(E) Representative rectal sections showing ATOH1^+^ICRs (red) in the control mice (Control) and in the DSS-colitis mice (DSS) on day 20.(F) Quantification of the ATOH1^+^ICR formation frequency in the rectum of DSS-colitis mice (n = 3) and control mice (n = 3). The number of ATOH1^+^ICR was normalized by the total number of crypts. Data are expressed as the mean ± SEM per 1,000 crypts. ^∗^p \< 0.0001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Collectively, we found that generation of ATOH1^+^ICRs was significantly promoted at the earliest phase of the tissue repair process in DSS-colitis mice, and thereby partly contributed to the regeneration of colitis-associated wounds.

Inflammatory Cytokines and Bacterial Components Coordinately Promote the Formation of ATOH1^+^ICRs {#sec2.5}
--------------------------------------------------------------------------------------------------

To obtain insight into the mechanism underlying the promotion of ATOH1^+^ICR formation in the colitic environment, the tdTomato^+^ IEC population in the rectum of DSS-colitis-induced *Atoh1*^*tdTomato*^ mice was collected ([Figure 5](#fig5){ref-type="fig"}A) and subjected to microarray analysis. MA plot analysis identified *Dll1* as one of the highly upregulated genes in the tdTomato^+^ IEC population of the DSS-colitis mice ([Figure 5](#fig5){ref-type="fig"}B). Consistently, a clear increase in the number of DLL1^+^tdTomato^+^ double-positive IECs was confirmed in the rectal tissue of the DSS-colitis mice ([Figure 5](#fig5){ref-type="fig"}C).Figure 5Inflammatory Cytokines and Bacterial Components Coordinately Promote the Formation of ATOH1^+^ICRs(A) Representative histogram of rectal tdTomato^+^ IECs in the DSS-colitis mice (red) and control mice (blue) on day 6.(B) MA plot demonstrating difference in global gene expression between tdTomato^+^ IECs of DSS-colitis mice and control mice.(C) Double immunostaining of DLL1 (green) and tdTomato (red) using colonic tissues of DSS-colitis mice and control mice at day 6. The number of tdTomato^+^DLL1^+^ double-positive cells was quantified by analysis of rectal tissue obtained from DSS-colitis mice (n = 3) and control mice (n = 3). Data are expressed as the mean ± SEM. ^∗^p \< 0.05.(D) The global gene expression data from (B) were compared with the registered NF-κB signaling gene set (M1983) through GSEA.(E) The global gene expression data from (B) were compared with the registered adult stem cell gene set (M1999) through GSEA.(F) *In vitro* analysis of ATOH1^+^ICR formation using colonic organoids from *Atoh1*^*tdTomato*^ mice. Organoids were cultured under DBZ-induced secretory lineage-differentiation conditions for 3 hr and subjected to *in vitro* lineage-tracing analysis following the addition of RU486 with cytokines or bacterial components (Ligands). The addition of PBS alone served as a control.(G) Phase-contrast view and tdTomato fluorescence view (red) of the organoids treated as shown in (F). The data are from organoids on day 6. Note that the organoids in the control condition (PBS) showed a scattered distribution pattern of tdTomato^+^ IECs, whereas those treated with the combination of TNF-α, IL-1β, LPS, and flagellin (TILF cocktail) clearly showed a continuous stream of tdTomato^+^ IECs (upper left inset).(H) Quantitative analysis of the *in vitro* lineage-tracing analysis. The number of organoids showing *in vitro* ATOH1^+^ICR was normalized by the total organoids that were established during the experimental period. The presented data are from three independent analyses including over 100 organoids from each experimental condition. Data are expressed as the mean ± SEM. ^∗^p \< 0.05.(I) Quantitative analysis of the *in vitro* lineage-tracing analysis. Data are expressed as the mean ± SEM (three independent analyses). ^∗^p \< 0.05. Piceatannol or IMD0354 was added at the same time as the TILF cocktail.(J) qPCR analysis of colonic organoids. Data are expressed as the mean ± SEM of values normalized against the expression of β-actin (three independent analyses). ^∗^p \< 0.05.(K) Single-cell organoid reconstruction assay of colonic organoids treated by TILF cocktail. Colonic organoids were treated as described in (F), and those TILF-treated tdTomato^+^ organoids were further subjected to single-cell passage. Picture shows organoids at day 5 after second passage from TILF addition (P2; Day5).(L) Single-cell organoid reconstruction assay using colonic IECs isolated from DSS-colitis mice or control mice at day 3.(M) Quantification of organoid reconstruction assay shown in (L), using DSS-colitis mice (n = 3) and control mice (n = 3). Data are expressed as the mean ± SEM. ^∗^p \< 0.001.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Pathway analysis of the microarray data additionally revealed that gene sets representing the general inflammatory response were most significantly upregulated. Furthermore, we found that the response to interleukin (IL)-1 and TNF-α was significantly upregulated in the ATOH1^+^ IECs of the DSS-colitis mice ([Figure S5](#mmc1){ref-type="supplementary-material"}A). The NF-κB pathway represents the major downstream signaling pathway shared by TNF-α and IL-1β ([@bib13]). A previous study highlighted the importance of constitutive NF-κB pathway activation in the de-differentiation of mouse small-intestinal villus IECs ([@bib23]). Our GSEA consistently revealed that the NF-κB pathway gene set was significantly upregulated in the tdTomato^+^ IECs of the DSS-colitis mice ([Figure 5](#fig5){ref-type="fig"}D), as were genes related to stem cell maintenance ([Figure 5](#fig5){ref-type="fig"}E). Thus, in DSS colitis, ATOH1^+^ IEC-derived cells appeared to gain stem cell-like gene expression under an increased activation level of the NF-κB pathway.

To validate the contribution of NF-κB signaling to ATOH1^+^ICR formation, we performed *in vitro* analyses using organoid culture. Colonic organoids from *Atoh1*^*tdTomato*^ mice were cultured under DBZ-induced differentiation conditions, which clearly promoted commitment to the ATOH1^+^ secretory cell lineage, and also promoted downregulation of ISC-specific genes ([Figure S5](#mmc1){ref-type="supplementary-material"}B). To induce activation of the NF-κB pathway, two representative bacterial components, such as lipopolysaccharide (LPS) and flagellin, were employed in addition to TNF-α and IL-1β. The combined addition of these ligands (TILF cocktail) clearly upregulated the expression of IL-8 in DBZ-treated colonic organoids ([Figure S5](#mmc1){ref-type="supplementary-material"}C) and induced the degradation of IκBα ([Figure S5](#mmc1){ref-type="supplementary-material"}D), which confirmed the activation of the NF-κB pathway in secretory cell-committed organoids. Using these secretory cell-committed organoids, we proved that addition of the TILF cocktail could induce the formation of colonic ATOH1^+^ICRs *in vitro* ([Figures 5](#fig5){ref-type="fig"}F and 5G). This *in vitro* formation of ATOH1^+^ICRs in secretory cell-committed organoids clearly required the addition of all ligands ([Figure 5](#fig5){ref-type="fig"}H). Specific blockade of the NF-κB pathway using small-molecule compounds ([Figure S5](#mmc1){ref-type="supplementary-material"}E) consistently inhibited the formation of ATOH1^+^ICRs in a dose-dependent manner ([Figures 5](#fig5){ref-type="fig"}I and [S5](#mmc1){ref-type="supplementary-material"}F). Thus, we found that the NF-κB pathway functions as a key pathway in promoting the exhibition of ISC properties by ATOH1^+^ IEC-derived cells. Accordingly, the addition of TILF ligands clearly upregulated the expression of ISC markers *Ascl2* and *Smoc2*, in addition to *Dll1* ([Figure 5](#fig5){ref-type="fig"}J), suggesting that the expression of these genes may play a key role in the inflammation-induced formation of ATOH1^+^ICRs. Such a TILF-cocktail-induced upregulation of ISC markers was never observed in organoids treated without DBZ ([Figure S5](#mmc1){ref-type="supplementary-material"}G). However, the expression level of *Lgr5* remained unchanged both in DBZ-treated and untreated organoids ([Figures 5](#fig5){ref-type="fig"}I and [S5](#mmc1){ref-type="supplementary-material"}G), possibly due to its low expression level in early reprogrammed ISCs.

To validate the ISC property of TILF-treated Atoh1^+^IEC-derived cells *in vitro*, we tested whether TILF-treated *Atoh1*^*tdTomoto*^ mice organoids could newly reconstruct tdTomato^+^ organoids and expand their progeny beyond passaging. As expected, TILF-treated organoids could reconstruct tdTomato^+^ organoids beyond passaging from single isolated cells ([Figure 5](#fig5){ref-type="fig"}K). Also, an increased number of tdTomato^+^ organoids was re-constructed from single isolated IECs that were recovered from the DSS-colitis mice ([Figures 5](#fig5){ref-type="fig"}L and 5M), indicating enrichment of cells retaining ISC-like properties.

ATOH1^+^ IECs Comprise Colitis-Associated Tumors and Acquire Tumor Stem Cell Properties {#sec2.6}
---------------------------------------------------------------------------------------

CAC develops through a pathway distinct from that of sporadic colon cancer ([@bib6], [@bib29]) and shows pathologic features such as high ATOH1 expression ([@bib10], [@bib19]). However, the precise role of ATOH1^+^ IECs in CACs remains uncertain. We have previously shown that TNF-α mediated activation of the NF-κB pathway in IECs plays an indispensable role in azoxymethane (AOM)-DSS tumor formation in mice ([@bib17]). Hence, we asked whether the tumors of AOM-DSS model mice ([@bib18]) harbor ATOH1^+^ tumor cells and exhibit features of CACs ([Figure 6](#fig6){ref-type="fig"}A). It was found that AOM-DSS tumors contained a substantial number of ATOH1^+^ tumor cells and expressed ATOH1 at a high level ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C). Furthermore, increased production of mucin was observed in these tumors ([Figure S6](#mmc1){ref-type="supplementary-material"}D), suggesting that they faithfully phenocopy CACs.Figure 6ATOH1^+^ IECs Contribute to the Formation of AOM-DSS-Induced Colitic Tumors and Acquire the Properties of Tumor Stem Cells(A) Experimental design combining the AOM-DSS tumor model and ATOH1^+^ IEC lineage tracing.(B) H&E staining and fluorescence images of a rectal tumor tissue section on day 56. A few isolated tdTomato^+^ cells (red) were found within the tumor tissue.(C) Stereoscopic view (upper panels) and tissue section (lower panels) of a massive rectal tumor (black and white arrowheads) on day 70.(D) Percentage ratio of tumor ATOH1^+^ICR or the area occupied by tdTomato^+^ tumor cells was analyzed in tumors at day 56 (n = 4) and day 70--80 (n = 8). Data are expressed as the mean ± SEM. ^∗^p \< 0.05, N.S., not significant.(E) Staining of serial sections showing ATOH1^+^, Ki-67^+^, and nuclear-localized β-catenin^+^ cells in the tumor ATOH1^+^ICR on day 70.(F) RNAscope ISH analysis showing a *Lgr5*^+^ (green) tumor cell (yellow arrowhead) within the tdTomato^+^ (red) tumor area.(G) *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice were treated as shown in (A). Lgr5-EGFP^+^ tdTomato^+^ double-positive tumor cells (yellow arrowhead) were found within the tumor ATOH1^+^ICRs of the rectal tumors on day 69, along with Lgr5-EGFP^+^ single-positive tumor cells in the surrounding tumor area (white arrowhead).(H) Organoid culture using AOM-DSS tumor tissues from *Atoh1*^*tdTomato*^ mice or normal colonic tissues from wild-type mice. Isolated cells were cultured in Wnt3a/R-Spondin-1-supplemented medium (ENRW) or Wnt3a/R-Spondin-1-depleted medium (EN). A merged view of the phase-contrast and tdTomato fluorescence (red) images is shown.(I) Growth of subcutaneous tumors initiated by transplantation of AOM-DSS tumor-cell-derived organoids (1 × 10^5^ cells, n = 3; 4 × 10^5^ cells, n = 3; AOM-DSS), normal colon-derived organoids (1 × 10^5^ cells, n = 3; normal colon organoid), or HT29 cells (4 × 10^5^ cells, n = 3; HT29) into nude mice. For the transplantation of AOM-DSS tumor cell-derived organoids, a mixture of tdTomato^+^ and tdTomato^−^ organoids was used. Data are expressed as the mean ± SEM. ^∗^ indicates p \< 0.001 of HT-29 and AOM-DSS (4 × 10^5^) compared with normal colon organoid.(J) Tissue analysis of the tumors formed through transplantation of AOM-DSS tumor cell-derived organoids (4 × 10^5^ cells). Macroscopic view (left panel) showing the distribution of tdTomato^+^ cells (red) in a mosaic pattern. Immunostaining for tdTomato (red) and Ki67 (green) revealing a cluster of Ki67^+^tdTomato^+^ double-positive cells (yellow arrowhead) within the tumor tissue. In addition, Ki67^+^tdTomato^−^ single-positive cells were found within the surrounding tumor tissue (white arrowhead).See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

At the early stage of AOM-DSS tumor labeling in *Atoh1*^*tdTomato*^ mice, only a few isolated tdTomato^+^ tumor cells were found (day 56, [Figure 6](#fig6){ref-type="fig"}B). However, clear expansion of the tdTomato^+^ area within the tumor was observed after day 70, which represented a continuous cluster of tdTomato^+^ tumor cells ([Figures 6](#fig6){ref-type="fig"}C and 6D). The ratio of these tumor ATOH1^+^ICRs among tumor-forming ducts did not increase during the tumor development ([Figure 6](#fig6){ref-type="fig"}D), but they clearly included Ki-67^+^ cells and ATOH1^+^ cells and showed nuclear translocation of β-catenin ([Figure 6](#fig6){ref-type="fig"}E). In contrast, they lacked expression of secretory cell markers other than MUC2 ([Figure S6](#mmc1){ref-type="supplementary-material"}E). Importantly, some of the tdTomato^+^ cells co-expressed tumor stem cell markers such as CD44 or CD133 ([@bib34], [@bib35]) ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Moreover, *Lgr5*^*+*^ cells were present in the tdTomato^+^ tumor clonal ribbons, as shown by the RNAscope ISH analysis ([Figure 6](#fig6){ref-type="fig"}F). Consistent with this finding, LGR5-EGFP^+^tdTomato^+^ double-positive tumor cells were found in the AOM-DSS tumors of the *Lgr5*^*EGFP*^*Atoh1*^*tdTomato*^ mice, in addition to LGR5-EGFP^+^ single-positive tumor cells ([Figure 6](#fig6){ref-type="fig"}G). Taken together, these results collectively indicated that ATOH1^+^ IECs contributed to the development of AOM-DSS tumors by acquiring tumor stem cell properties. However, the existence of LGR5-EGFP^+^ single-positive tumor cells indicated that these AOM-DSS tumors were mosaic and potentially consisted of a heterogeneous population of ATOH1^+^ and ATOH1^−^ tumor stem cells.

As expected, we observed that both tdTomato^+^ and tdTomato^−^ AOM-DSS tumor cell organoids could be established *in vitro* ([Figure 6](#fig6){ref-type="fig"}H). The tdTomato^+^ AOM-DSS tumor organoids consisted solely of tdTomato^+^ cells and shared the Wnt-independent growth ability of the tdTomato^−^ tumor organoids. Furthermore, they could be maintained across several passages and form tumors via subcutaneous transplantation into nude mice in a dose-dependent manner ([Figure 6](#fig6){ref-type="fig"}I). The re-produced tumors of the nude mice consisted of both tdTomato^+^ and tdTomato^−^ proliferating cells ([Figure 6](#fig6){ref-type="fig"}J), which conserved the mosaic features of the original AOM-DSS tumor. These results collectively indicated that AOM-DSS tumors harbored ATOH1^+^ IEC-derived tumor stem cells, in addition to tumor stem cells of other origins. Thus, colitis-associated tumorigenesis may represent another pathologic condition in which the acquisition of stem cell-like properties by ATOH1^+^ IECs can be promoted.

Discussion {#sec3}
==========

In our lineage-tracing model, the frequency of forming colonic ATOH1^+^ICRs reached 250--300 ribbons per mouse under homeostatic conditions and 1,500--1,800 ribbons per mouse in DSS colitis, which certainly exceeded previous models ([@bib28], [@bib30], [@bib32]). Thus, our results highlight the contribution of ATOH1^+^ IECs in the maintenance of the ISC pool, particularly in the colon. We also succeeded in clearly visualizing the dramatic and time-dependent increase in the frequency of colonic ATOH1^+^ICR formation in the DSS-colitis model. This result underpins the previous report of DCLK1^+^ IECs, which indicated the increased ISC conversion of colonic DCLK1^+^ IECs in DSS-colitis mice but did not successfully identify increased formation of DCLK1^+^ IEC-derived clonal ribbons ([@bib32]).

Previous studies have identified at least three subpopulations of small-intestinal ATOH1^+^ IECs that may retain their potential to undergo conversion back to ISCs: ATOH1^+^LGR5^+^ double-positive IECs at the +1 to +3 position ([@bib11]), ATOH1^+^LRCs at the +4 position ([@bib3]), and ATOH1^+^DLL1^+^ IECs at the +5 position ([@bib30]). However, the origin of cells that can form colonic ATOH1^+^ICRs may be heterogeneous and may differ from the small-intestinal counterparts. For example, the existence of colonic LRCs is not well confirmed, and small-intestinal LRCs have never been shown to form clonal ribbons under homeostatic conditions ([@bib11]). The existence of ATOH1^+^LGR5^+^ double-positive IECs in the normal or colitic colon has never been identified in previous reports. In our current analysis, we successfully identified a rare population of ATOH1^+^LGR5^+^ double-positive cells both in the small intestine and colon ([Figure 2](#fig2){ref-type="fig"}C). However, most of these ATOH1^+^LGR5^+^ double-positive cells appeared to be lost under induction of DSS colitis ([Figure 4](#fig4){ref-type="fig"}C). Therefore, ATOH1^+^LGR5^+^ double-positive cells may be the dominant origin of ATOH1^+^ICRs under homeostatic conditions but may be less involved in ATOH1^+^ICR formation under DSS colitis.

We have previously shown that DLL1^+^ IECs reside at the lowest part of the crypts, both in the small intestine and in the colon ([@bib25]). Furthermore, an increase of DLL1^+^ colonic IECs was clearly confirmed in DSS-colitis mice ([Figure 5](#fig5){ref-type="fig"}C) ([@bib25]). Therefore, the DLL1^+^ population of ATOH1^+^ IEC-derived cells may be one of the candidate subpopulations that can form ATOH1^+^ICRs in the colon, especially under inflammatory conditions. However, it remains possible that the increase of ATOH1^+^ICR formation in DSS-colitis mice depends on the concerted contribution of other unknown subpopulations. A similar de-differentiation has been observed in the airway secretory lineage IECs, suggesting that re-acquiring stem cell properties is inversely related to their maturity ([@bib27]).

Our analysis of ATOH1^+^ IECs in DSS-colitis mice successfully identified cytokine- or bacterial-component-induced NF-κB activation as a key event in promoting ATOH1^+^ICR formation ([Figures 5](#fig5){ref-type="fig"}D--5J), which is consistent with a previous study involving genetic NF-κB activation in villus IECs ([@bib23]). Because NF-κB pathway activation in secretory lineage-committed organoids appeared to upregulate the expression of *Dll1* ([Figure 5](#fig5){ref-type="fig"}J), it may be possible that NF-κB signaling promotes ATOH1^+^ICR formation via generating an increased number of DLL1^+^ secretory progenitor cells.

In the AOM-DSS model, ATOH1^+^ IECs acquired the properties of tumor stem cells and appeared to contribute to the mosaic development of tumors ([Figure 6](#fig6){ref-type="fig"}C). At present, it remains uncertain to what extent these cells precisely contribute to the overall development and progression of these tumors. The contribution of ATOH1^+^ tumor cells to the overall tumor formation may be underestimated due to the limited labeling efficiency of the present lineage-tracing system. However, the clear mosaic pattern harboring both ATOH1^+^ and ATOH1^−^ tumor stem cells may illustrate one of the reasons why colitis-associated tumors are highly resistant to chemotherapeutic approaches. Recently, it has been shown that human colorectal cancer cells can inter-convert between differentiated tumor cells and tumor stem cells, thereby exhibiting resistance to tumor stem cell-specific ablation ([@bib26]). Further studies will be needed to confirm the contribution of ATOH1^+^ tumor cells to the heterogeneous development and progression of CACs found in IBD patients. Nevertheless, our results newly indicate ATOH1^+^ tumor cells as an additional therapeutic target cell population for CACs.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

C57BL/6J mice and BALB/cAJcl-*nu*/*nu* mice were purchased from Japan Clea.

*Atoh1*^*Cre-PGR*^ ([@bib20]), *Lgr5-EGFP-IRES-creERT2* ([@bib1]), *Rosa26-LSL-tdTomato* mice ([@bib12]), or *Apc*^*Min*^ mice were purchased from the Jackson Laboratory. *Apc*^*fl/fl*^ mice were provided by RIKEN BRC ([@bib4]). The primers used for genotyping are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. Male and female mice at 8--10 weeks of age were used. All animal experiments were approved by the Animal Care and Use Committee of Tokyo Medical and Dental University (0160326A and 0170276A). For the induction of Cre-mediated recombination, mifepristone (RU486, 2 mg/body, Sigma-Aldrich) or tamoxifen (TMX, 2 mg/body, Sigma-Aldrich) was injected intraperitoneally into mice carrying the *Atoh1*^*Cre-PGR*^ allele or the *Lgr5-EGFP-IRES-creERT2* allele, respectively.

Immunohistochemistry {#sec4.2}
--------------------

Immunohistochemistry was performed as previously described ([@bib16]). The primary antibodies employed for these assays are listed in [Table S2](#mmc1){ref-type="supplementary-material"}. Antigen retrieval using citrate buffer was required for the staining of ATOH1, HES1 ([@bib8]), chromogranin A (CHGA), DCLK1, Ki-67, tdTomato, and β-CATENIN.
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